Clovis Oncology Aktie (A1JPJY | CLVS

Was macht Clovis Oncology?

Unternehmensprofil

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Their development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from them.

Chart der Clovis Oncology Aktie

Charttool öffnen

Aktuelle Nachrichten zu Clovis Oncology

Unsere neuesten Artikel zu Clovis Oncology

Im Rampenlicht: Das sind 20 stark geshortete Aktien

Die Wallstreetbets-Gruppe auf Reddit ist im Moment in aller Munde. Dabei hat es die Gruppe vor allem auf stark geshorteten Aktien abgesehen. Diese Unternehmen haben die höchste Shortquote.

Das berichten andere über Clovis Oncology

Global Prostate Health Market Size To Worth USD 78.03 Billion By 2033 | CAGR Of 9.12%

The Global Prostate Health Market Size was Valued at USD 32.6 Billion in 2023 and the Worldwide Prostate Health Market Size is Expected to Reach USD 78.03 Billion by 2033,...

[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global PARP Inhibitors Market size & share revenue...